Aug 4, 2023
January 25, 2025
This week’s newsletter included:
-
2023 MDMA Medical Technology Executive Forum
-
Quansys Biosciences and the Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research
-
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
-
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
-
Renalytix Forms Clinical Advisory Board
-
Jen Brown Appointed Chair of Department of Entrepreneurship & Strategy
-
Utah Business Best Companies to Work For
-
Salt Lake City Named One of Six Best American Cities for Entrepreneurs
-
Teva Reports Second Quarter 2023 Financial Results
-
BD Reports Third Quarter Fiscal 2023 Financial Results
-
Five O’Clock Podcast: Howard McLeod on the Rising Impact of Genomic Research on Medicine
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
